IL2 and melanoma: We also analyzed samples from dogs in a third trial, the University of Wisconsin (UW) cohort, where dogs with melanoma were treated with low-dose molecular targeted radionuclide therapy (MTRT), external beam radiation therapy (EBRT) and intratumoral injection of GD2/IL-2 fusion immunocytokine (Figure 3C).